“The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN”, VER, vol. 8, no. 5s, pp. 154–161, Nov. 2025, doi: 10.64149/J.Ver.8.5s.154-161.